DIABETES - The Salt Lake Tribune http://www.sltrib.com/feeds/topics/DIABETES News from The Salt Lake Tribune en-us webmaster@sltrib.com (Webmaster) Winner of Utah kick scooter marathon relay: diabetes awareness http://www.sltrib.com/sltrib/news/58177265-78/ride-crusaders-razor-diabetes.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/news/58177265-78/ride-crusaders-razor-diabetes.html.csp">Winner of Utah kick scooter marathon relay: diabetes awareness</a></h4> <span class="author vcard"><span class="fn">By Steve Luhm</span></span> <span class="source-org vcard"><span class="org fn"> The Salt Lake Tribune</span></span> <h5><span class="updated" title="2014-07-13T13:37:03.723-06:00">Updated Jul 13, 2014 01:37PM MDT</span></h5> <div class ="entry-content">They made a grueling 3,000-foot climb out of Utah’s southwest desert, endured a blinding rainstorm, dodged livestock on a country road illuminated only by moonlight, heard impatient drivers honk their horns when forced to slow behind them and — finally — navigated the busy streets of the Wasatch Front. Twenty-four members of a nonprofit organization called Razor Crusaders took a tour of Utah during the last three days — starting in St. George and finishing amid a carnival-like celebration at Dav...</div> <h5><a rel="item-license" href="http://www.sltrib.com/pages/privacy"> Copyright 2013 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58177265@www.sltrib.com Sun, 13 Jul 2014 13:37:03 MDT FDA approves inhalable diabetes drug Afrezza http://www.sltrib.com/sltrib/money/58124065-79/insulin-diabetes-drug-afrezza.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/money/58124065-79/insulin-diabetes-drug-afrezza.html.csp">FDA approves inhalable diabetes drug Afrezza</a></h4> <span class="author source-org vcard"><span class="org fn">The Associated Press</span></span> <h5><span class="updated" title="2014-06-27T14:32:04.911-06:00">Updated Jun 27, 2014 02:32PM MDT</span></h5> <div class ="entry-content">Washington • The Food and Drug Administration on Friday approved a long-delayed inhalable diabetes medication to help patients control their blood sugar levels during meals. The FDA cleared MannKind Corp.’s drug Afrezza, a fast-acting form of insulin, for adults with the most common form of diabetes that affects more than 25 million Americans. The approval decision comes more than three years after the agency first asked MannKind to run additional clinical studies on the drug. Diabetes is a chro...</div> <h5><a rel="item-license" href="#license-581240652014-06-27T14:32:04.911-06:00" id="#license-2014-06-27T14:32:04.911-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58124065@www.sltrib.com Fri, 27 Jun 2014 14:32:04 MDT